Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents

Ruo-Jun Man, Nasreen Jeelani, Chongchen Zhou, Yu-Shun Yang

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)825-838
Number of pages14
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume21
Issue number7
DOIs
Publication statusPublished - 2021
Externally publishedYes

Austrian Fields of Science 2012

  • 305905 Medical informatics

Keywords

  • Anti-cancer agents
  • quinoline derivatives
  • marketed drugs
  • clinical trials
  • molecular targets
  • major mechanisms
  • TYROSINE KINASE INHIBITOR
  • TOPOISOMERASE-I INHIBITOR
  • DUAL PI3K/MTOR INHIBITOR
  • GROWTH-FACTOR
  • DNA TOPOISOMERASES
  • HEPATOCELLULAR-CARCINOMA
  • LIPOSOMAL FORMULATION
  • MOLECULAR-MECHANISMS
  • SELECTIVE ACTIVATION
  • CAMPTOTHECIN ANALOG
  • Major mechanisms
  • Clinical trials
  • Quinoline derivatives
  • Marketed drugs
  • Molecular targets

Fingerprint

Dive into the research topics of 'Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents'. Together they form a unique fingerprint.

Cite this